Status:
COMPLETED
Intravaginal Laser Treatment of Mild and Moderate Stress Incontinence
Lead Sponsor:
University Hospital Tuebingen
Conditions:
Stress Incontinence, Female
Eligibility:
FEMALE
18+ years
Phase:
NA
Brief Summary
The aim of the study is to evaluate the effectiveness of laser therapy as a non-surgical treatment option in patients with mild and moderate stress incontinence.
Detailed Description
The aim of the study is to evaluate the effectiveness of laser therapy as a non-surgical treatment option in patients with mild and moderate stress incontinence.
Eligibility Criteria
Inclusion
- Light or moderate stress incontinence
- mixed urine incontinence with predominance of the stress component
- written informed consent
Exclusion
- Pregnancy
- patients treated radiotherapy in the small basin
- connective tissue disorders (e.g., Ehlers-Danlos syndrome, Marfan syndrome)
- patient with or after malignant disease of the uterus, ovaries, vagina and vulva
- former surgery due to stress incontinence (except for the patients who had a TVT insert with removal of the TVT)
- Descensus genitalis\> POPQ Stage 1
- former surgery due to a genital lowering with vaginal netting
Key Trial Info
Start Date :
August 31 2017
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
September 1 2018
Estimated Enrollment :
30 Patients enrolled
Trial Details
Trial ID
NCT03267719
Start Date
August 31 2017
End Date
September 1 2018
Last Update
July 22 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Department for Women's Health
Tübingen, Germany, 72076